Literature DB >> 26154398

Correlation of changes in the mandible and retina/choroid vasculature of a rat model of BRONJ.

James L Borke1, Bennett McAllister2, Tiffenie Harris2, Maryke Neiberg2, Chestine Guevarra-Toth3, Sadanand Fulzele4, Charles Stoianovici5, Carlos Guerra5.   

Abstract

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) causes bones of the mandible and maxilla to become necrotic and protrude into the oral cavity. Compromised blood supply to bone is also a feature of BRONJ. The design of this study was first to use our established technique of molar extraction and IV bisphosphonate injection to produce features of BRONJ in rats that mimic the human disease; second to confirm vascular changes in the mandible and eye using micro-CT of vascular casts, and image analysis of retina/choroid images; and third to show parallel bisphosphonate-induced changes in the structure and markers of the vasculature of the bone and eye. The results of this study show structural changes in the eye and mandible as well as biochemical changes including the up-regulation of VEGF in response to the bisphosphonate-associated ischemia. These changes are not associated with angiogenesis in either the eye or mandible as determined by reduced vascular complexity. These results suggest that observations of direct changes to the vasculature in the retina/choroid structures of the eye in patients taking bisphosphonates could serve as a window to the progression of debilitating changes occurring as a result of bisphosphonate therapy.
Copyright © 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRONJ; Bisphosphonate; Choroid/retina; MRONJ

Mesh:

Year:  2015        PMID: 26154398     DOI: 10.1016/j.jcms.2015.05.021

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  7 in total

1.  Oral health condition in cancer patients under bisphosphonate therapy.

Authors:  Rogério Jardim Caldas; Héliton Spíndola Antunes; Camila de Oliveira Rodini Pegoraro; Fábio Ribeiro Guedes; Paulo Sérgio da Silva Santos
Journal:  Support Care Cancer       Date:  2021-06-18       Impact factor: 3.603

2.  Antiresorptive drug-related changes of the mandibular bone densitiy in medication-related osteonecrosis of the jaw patients.

Authors:  Nils Heim; Werner Götz; Franz-Josef Kramer; Anton Faron
Journal:  Dentomaxillofac Radiol       Date:  2019-09-17       Impact factor: 2.419

Review 3.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

Review 4.  Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview.

Authors:  Andreas Max Pabst; Maximilian Krüger; Sebastian Blatt; Thomas Ziebart; Roman Rahimi-Nedjat; Elisabeth Goetze; Christian Walter
Journal:  Dent J (Basel)       Date:  2016-12-26

5.  Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats.

Authors:  Mitsuhiko Imada; Takahiro Yagyuu; Yoshihiro Ueyama; Masahiko Maeda; Kazuhiko Yamamoto; Satoshi Kurokawa; Jun-Ichiro Jo; Yasuhiko Tabata; Yasuhito Tanaka; Tadaaki Kirita
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

6.  Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.

Authors:  Jing Wen Li; Jing Yi Wang; Ru Qing Yu; Lei Huo; Li Wu Zheng
Journal:  BMC Res Notes       Date:  2022-01-10

7.  Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis.

Authors:  Dan Zhao; Dexuan Xiao; Mengting Liu; Jiajie Li; Shuanglin Peng; Qing He; Yue Sun; Jingang Xiao; Yunfeng Lin
Journal:  Int J Oral Sci       Date:  2022-04-27       Impact factor: 24.897

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.